{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:25:35Z","timestamp":1785410735361,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejca.2021.12.010","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T04:56:50Z","timestamp":1642741010000},"page":"140-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortality"],"prefix":"10.1016","volume":"163","author":[{"given":"Ardine M.J.","family":"Reedijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-1823","authenticated-orcid":false,"given":"Auke","family":"Beishuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2419-3930","authenticated-orcid":false,"given":"Jan Willem W.","family":"Coebergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3026-8721","authenticated-orcid":false,"given":"Bianca A.W.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7619-7845","authenticated-orcid":false,"given":"Leontien C.M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konnie M.","family":"Hebeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.C.","family":"Loeffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1241-5866","authenticated-orcid":false,"given":"Henrike E.","family":"Karim-Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.12.010_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2020.04.011","article-title":"Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017","volume":"134","author":"Reedijk","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib2","series-title":"Pediatric lymphomas","first-page":"91","article-title":"Biology and pathology of pediatric non-Hodgkin lymphoma","author":"Perkins","year":"2007"},{"key":"10.1016\/j.ejca.2021.12.010_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.24095\/hpcdp.38.3.01","article-title":"Childhood cancer incidence in Canada: demographic and geographic variation of temporal trends (1992-2010)","volume":"38","author":"Xie","year":"2018","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"10.1016\/j.ejca.2021.12.010_bib4","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/ijc.29924","article-title":"International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years","volume":"138","author":"Linet","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(18)30423-6","article-title":"Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study","volume":"19","author":"Steliarova-Foucher","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/bjh.15491","article-title":"Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB\/LMB 96: a report from the FAB\/LMB 96 study group","volume":"182","author":"Cairo","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2021.12.010_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcp\/aqz078","article-title":"Molecular genetics in the diagnosis and biology of lymphoid neoplasms","volume":"152","author":"Lim","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejca.2021.12.010_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2017.09.030","article-title":"Site of childhood cancer care in the Netherlands","volume":"87","author":"Reedijk","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib9","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2014.59.5827","article-title":"Non-hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead","volume":"33","author":"Minard-Colin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","article-title":"Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Munster Group","volume":"13","author":"Reiter","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib11","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2021.12.010_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2008.18.1487","article-title":"Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group","volume":"27","author":"Brugieres","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib14","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.2010.28.5999","article-title":"Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial","volume":"28","author":"Le Deley","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib15","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/0959-8049(95)00355-M","article-title":"Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries","volume":"31A","author":"van der Sanden","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib16","series-title":"Cause of death statistics","year":"2019"},{"key":"10.1016\/j.ejca.2021.12.010_bib17","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2021.12.010_bib18","series-title":"International classification of diseases for oncology (ICD-O-3)","author":"Percy","year":"2000"},{"key":"10.1016\/j.ejca.2021.12.010_bib19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.20910","article-title":"International classification of childhood cancer, third edition","volume":"103","author":"Steliarova-Foucher","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib20","first-page":"1860","article-title":"Report of the committee on hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2021.12.010_bib21","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S1470-2045(15)00539-2","article-title":"Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines","volume":"17","author":"Gupta","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.12.010_bib23","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.2009.26.6791","article-title":"Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia","volume":"28","author":"Meinhardt","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib24","series-title":"Statistical methods for registries. Cancer registration: principles and methods","first-page":"126","author":"Boyle","year":"1991"},{"key":"10.1016\/j.ejca.2021.12.010_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.ejca.2006.05.013","article-title":"Geographical comparison of cancer survival in European children (1988-1997): report from the Automated Childhood Cancer Information System project","volume":"42","author":"Sankila","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjc.6605503","article-title":"Trends in incidence of childhood cancer in Australia, 1983-2006","volume":"102","author":"Baade","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/cas.13457","article-title":"Childhood cancer incidence and survival in Japan and England: a population-based study (1993-2010)","volume":"109","author":"Nakata","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejca.2021.12.010_bib28","first-page":"83","article-title":"Childhood and adolescent cancer statistics","volume":"64","author":"Ward","year":"2014","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejca.2021.12.010_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/bjh.16491","article-title":"Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in The Netherlands: a population-based study during 1990-2015","volume":"189","author":"Reedijk","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2021.12.010_bib31","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.bjc.6605985","article-title":"Population-based survival estimates for childhood cancer in Australia during the period 1997-2006","volume":"103","author":"Baade","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study","volume":"15","author":"Gatta","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.12.010_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2021.12.010_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejca.2009.09.011","article-title":"Childhood cancer mortality in Europe, 1970-2007","volume":"46","author":"Bosetti","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib35","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ejca.2003.03.001","article-title":"Trends in cancer mortality at age 15 to 24 years in Europe","volume":"39","author":"Levi","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.12.010_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/leu.2015.230","article-title":"Improved survival in adult patients with acute lymphoblastic leukemia in The Netherlands: a population-based study on treatment, trial participation and survival","volume":"30","author":"Dinmohamed","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2021.12.010_bib37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41375-020-01024-0","article-title":"Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015","volume":"35","author":"Reedijk","year":"2020","journal-title":"Leukemia"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492101265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492101265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:35:38Z","timestamp":1760733338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492101265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":36,"alternative-id":["S095980492101265X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.12.010","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortality","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}